1002-16: Pharmacologic Treatment of Schizophrenia: How Far Have We Come?

4.73 (15 votes)

Recorded On: 06/10/2016

  • Registration Closed

1002-16: Pharmacologic Treatment of Schizophrenia: How Far Have We Come?

This dynamic presentation will increase your knowledge of evidence based treatment decisions for persons diagnosed with Schizophrenia. Dr. Kane provides an overview of the comprehensive specialty care needed for first episode patients. He describes evidence based treatment methods that will assist in increased numbers of patients consistently taking their medications and living healthier lives.

Presenter: John M. Kane, MD

Disclosures: The speaker has indicated a significant financial interest or other affiliation with Honorarium or Consultant for Alkermes, Forum, Intra Cellular Therapies, Janssen, Lundbeck, Otsuka, Sunovion, Teva, Reviva. Shareholder in Medavante, Vanguard, LB Pharma.  Off-label uses will not be discussed during this presentation. The activity planners have no conflicts of interest to disclose.

Session Length:  90 minutes

Target Audience:  RN, APRN

Session Objectives:
Upon completion of this presentation, the participant will be able to:

1. Increase understanding of comprehensive specialty care in first episode patients.
2. Increase knowledge of issues surrounding adherence in medication-taking.
3. Increase knowledge of long acting injectable and psychotics.
4. Increase knowledge of clozapine indications and use.

Keywords: Schizophrenia, Evidence based treatment, Medications, Long acting injectibles

Continuing Nursing Education
1.5 contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post test before the expiration date. You will have 5 tries to correctly answer the questions on the post test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The content of this CNE activity pertains to pharmacology.  Because states' requirements may vary, contact your Board of Nursing for more information.

The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Originally Presented
APNA 14th Annual Clinical Psychopharmacology Institute
Hyatt Regency Baltimore on the Inner Harbor
Friday, June 10, 2016
8:00am - 9:30am

Release Date:  July 29, 2016
The contact hours for this session expire: September 1, 2019

Components visible upon registration.